6-KThe Wire
Alvotech files 6-K
Filed Jun 4, 2026 · 1mo ago · Accession 0001171843-26-003911
Plain English
Alvotech announced the resubmission of Biologics License Applications (BLAs) to the U.S. Food and Drug Administration (FDA) for two proposed biosimilars, AVT05 and AVT06. The company also announced that meeting minutes and voting results from its 2026 Annual General Meeting would be published on its investor portal.
Filing details
- Company
- Alvotech
- Ticker
- ALVO
- CIK
- 1898416
- Form type
- 6-K
- Filing date
- Jun 4, 2026
- Report date
- Jun 4, 2026
- Document
- f6k_060426.htm
- Size
- 20 KB